REG - Housing Dev Fin Corp - Meeting of Committee of Directors

Housing Development FinanceAnnouncement

16/06/2020 13:10

RNS Number : 1361Q
  
Housing Development Fin. Corp. Ltd.
  
16 June 2020
  
 

 
 
Ref. No.: SE/2020-21/66
 
June 16, 2020
 
BSE Limited                                                               National Stock Exchange of India Limited
P. J. Towers                                                                 Exchange Plaza, Plot No. C/1, G Block,
Dalal Street                                                                 Bandra-Kurla Complex
Mumbai 400 001                                                        Bandra (East), Mumbai 400 051
 
Kind Attn: Sr. General Manager                               Kind Attn: Head - Listing 
      DCS - Listing Department
 
Dear Sirs,
 
Ref:    Intimation under Regulations 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) and SEBI (Prohibition of Insider Trading) Regulations, 2015
 
Sub:    Seeking shareholders' approval for raising funds
 
In accordance with the captioned regulations, we wish to inform you that a meeting of the Committee of Directors of the Corporation, duly constituted by the Board of Directors, will be held on Friday, June 19, 2020 to consider seeking shareholders' approval for raising of funds by issue of equity shares and/or other securities through any permissible mode(s), subject to such approvals as may be required.
 
The outcome of the said meeting will be submitted to you, in accordance with the Listing Regulations.
 
We request you to bring the above to the notice of all concerned.
 
Thank you.
 
Yours faithfully,
For Housing Development Finance Corporation Limited
 
 
 
Ajay Agarwal
Company Secretary
 
cc:        London Stock Exchange,
            10, Paternoster Square, London, EC4M 7LS
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
MSCSFMFEMESSESM